Spring allergy symptoms will start to appear soon in parts of the country. Many allergists advise their patients to set a reminder for Valentine’s Day to start taking allergy medications.
A special article in Annals of Allergy, Asthma and Immunology reports on the findings of a roundtable discussion that focused on challenges that people with skin of color with atopic dermatitis and food allergy often experience based on their skin type, their comfort level with health care providers, where they live, and many other sociodemographic factors.
Two new yardsticks, Clinical Guidance for the Use of Dupilumab in Eosinophilic Esophagitis: and A Yardstick and Yardstick for Managing Cough. Part 1: in Adults and Adolescent Patients >14 years of age have been published in Annals of Allergy, Asthma and Immunology, ACAAI’s scientific journal.
Four New Year’s resolutions from the American College of Allergy, Asthma and Immunology that those who suffer from allergies or asthma may want to consider.
Keep allergy and asthma triggers top of mind as you map out what your holidays will look like this year.
Allergist Kathleen May, MD, of Augusta, GA was installed as president of the American College of Allergy, Asthma and Immunology at the ACAAI Annual Scientific Meeting on November 13 in Louisville, KY.
La alergista Kathleen May, MD, de Augusta, GA, fue designada como presidenta del Colegio Americano de Alergia, Asma e Inmunología en la Reunión Científica Anual del ACAAI, el 13 de noviembre en Louisville, KY.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI muestra que incluso en los estados con fuertes leyes de inhaladores/albuterol de reserva, los administradores escolares y los médicos prescriptores temen la responsabilidad al prescribir y administrar los inhaladores de reserva.
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that even in states with strong stock inhaler/albuterol laws, school administrators and prescribing clinicians fear liability in prescribing and administering the stock inhalers.
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks.
A new study being presented at this year’s ACAAI Annual Scientific Meeting suggests that early morning hours are better than later in the afternoon for dodging pollen.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI muestra que el sexo puede ser un desencadenante no diagnosticado de las exacerbaciones del asma.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año sugiere que las primeras horas de la mañana son mejores que las últimas de la tarde para evitar el polen.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra niveles elevados de alérgenos de gatos y perros, así como de glucanos β-D y endotoxinas en modelos telefónicos simulados.
Un nuevo estudio que se presentó en la Reunión Científica Anual del ACAAI de este año muestra que de los bebés de 0 a 24 meses que acudieron al servicio de urgencias por anafilaxia, pocos requirieron hospitalización y la mayoría pudo irse a casa después de unas horas de observación.
Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra que un tratamiento que usa una tecnología de edición genética de repeticiones palindrómicas cortas, agrupadas y regularmente interespaciadas logró aliviar la inflamación y reducir la frecuencia de los ataques.
A new study being presented at this year’s ACAAI Annual Scientific Meeting in Louisville, KY, showed elevated levels of cat and dog allergens, as well as β-D glucans (BDG) and endotoxin on simulated phone models.
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that, in infants aged 0-24 months who presented to the emergency department for anaphylaxis, few required hospitalization and most were able to go home after a few hours of observation.
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that only half of food allergic adult patients have immediate access to epinephrine, and 36% of adults believe epinephrine auto injectors can cause negative or life-threatening effects.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI muestra que solo la mitad de los pacientes adultos alérgicos a los alimentos tienen acceso inmediato a la epinefrina y que el 36 % de los adultos creen que los autoinyectores de epinefrina pueden causar efectos negativos o potencialmente mortales.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right